Key Takeaway
Staying on top of your GLP-1 blood work tracking is one of the most important things you can do while on treatment. Your weekly injection does a lot more than suppress appetite. It changes your blood sugar, your cholesterol, your kidney markers, and more.
Staying on top of your GLP-1 blood work tracking is one of the most important things you can do while on treatment. Your weekly injection does a lot more than suppress appetite. It changes your blood sugar, your cholesterol, your kidney markers, and more. Regular lab work helps your provider catch problems early and confirm that your treatment is working the way it should.
Key Takeaways: - Baseline Labs Before Starting Treatment - Key Markers to Track During Treatment - Learn how often to get blood work done - Learn how to organize and share your results - Red Flags That Require Immediate Attention
Think of blood work as your body's report card. Here is what to test and when.
Baseline Labs Before Starting Treatment
Before your first dose, your provider should order a set of baseline labs. These give you a starting point so you can measure how your body changes on treatment.
The most common baseline panel includes A1C (your three-month blood sugar average), fasting glucose, a lipid panel (total cholesterol, LDL, HDL, triglycerides), kidney function markers (BUN and creatinine), liver enzymes (ALT and AST), thyroid function (TSH), and a complete blood count.
Some providers also order a vitamin B12 level and a vitamin D level at baseline. Both of these can drop during treatment because you are eating less food overall.
Your A1C is especially important. If it comes back above 5.7, you may have pre-diabetes. Above 6.5 indicates diabetes. This matters because it can affect your and which medication your provider recommends.
Keep a copy of every lab result. Whether you use a folder, a spreadsheet, or the FormBlends app, having your numbers in one place makes trends easy to spot.
"GLP-1 receptor agonists represent the most significant advance in obesity pharmacotherapy in decades. For the first time, we have medications that produce weight loss approaching what was previously only achievable through bariatric surgery.") Dr. Robert Kushner, MD, Northwestern University, speaking at ObesityWeek 2023
Key Markers to Track During Treatment
Once you start your GLP-1 medication, certain lab values deserve close attention. Here are the most important ones and what changes to expect.
A1C and fasting glucose should improve within three months. Studies suggest semaglutide can reduce A1C by 1.0 to 1.8 points depending on the dose. Even if you do not have diabetes, your fasting glucose may drop into a healthier range.
Lipid panel changes often surprise people. Triglycerides may drop significantly, sometimes by 20 to 30 percent. LDL cholesterol may decrease modestly. HDL cholesterol sometimes increases. These improvements happen partly from weight loss and partly from direct metabolic effects.
Free Download: GLP-1 Progress Report Template Organize your lab results, weight trends, and side effects in one clean document you can share with your provider. Get yours free (we'll email it to you instantly.
[Download CTA Button]
Kidney function markers deserve monitoring because dehydration is common on GLP-1 treatment. If you are not drinking enough water, your creatinine may creep up. The FLOW trial showed that semaglutide can actually be , but staying hydrated is still critical.
Liver enzymes often improve as you lose weight, especially if you had fatty liver disease. A drop in ALT is a good sign that liver fat is decreasing.
How Often to Get Blood Work Done
The timing of your lab work depends on your health history and your provider's preferences. However, a common schedule looks like this.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Try the BMI Calculator →At baseline, get a full panel before starting medication. At three months, repeat A1C, fasting glucose, lipid panel, and kidney function. This is your first checkpoint to see how the medication is affecting your metabolic markers.
At six months, run the full panel again including liver enzymes and thyroid function. By this point, you should see meaningful changes if the medication is working well.
After six months, most providers shift to every six months for routine labs. However, if you have diabetes, kidney disease, or other conditions, your provider may want labs more frequently.
If you change medications, such as , your provider may want fresh baseline labs before starting the new drug.
Do not skip lab work even if you feel great. Some important changes happen silently. Your kidney function could decline without symptoms. Your thyroid could shift without obvious signs. Lab work catches these things early.
How to Organize and Share Your Results
Raw lab numbers are not very useful on their own. What matters is the trend over time. A single elevated creatinine might mean nothing. Three consecutive increases tell a story.
Create a simple tracking sheet with columns for the date, each lab marker, and notes about your current dose. When you plot your A1C over six months alongside your weight trend, you start to see how the two connect.
Many electronic health portals let you download your results as a PDF. Save these in a dedicated folder. Some people prefer to manually enter key numbers into a spreadsheet so they can create their own charts.
Before each provider visit, pull together a one-page summary. Include your current dose, your weight trend since the last visit, any side effects, and the three or four most important lab values. This makes your appointment more efficient and productive.
The FormBlends app can store your lab results alongside your dose history and weight data. Having everything in one place saves time and helps your provider see the full picture during consultations.
Red Flags That Require Immediate Attention
Most lab changes on GLP-1 treatment are positive. But certain results should prompt a conversation with your provider right away.
A rising creatinine combined with symptoms like dark urine or reduced urination could signal dehydration or kidney stress. Your provider may want to check electrolytes and adjust your hydration plan.
A significant jump in lipase or amylase could indicate pancreatic inflammation. This is rare but serious. If you also have severe abdominal pain, seek medical attention immediately. Understanding helps you know what to watch for.
A TSH that moves outside the normal range needs follow-up. While GLP-1 medications carry a theoretical thyroid concern based on animal studies, changes in TSH are more commonly related to weight loss itself affecting thyroid hormone needs.
A sudden drop in A1C below 5.0 in someone taking insulin or sulfonylureas could indicate hypoglycemia risk. Your provider may need to reduce those other medications.
When in doubt, call your provider. A quick phone call about an unusual lab result is always better than waiting for your next scheduled visit.
Frequently Asked Questions
Do I need lab work before starting GLP-1 medication?
Most providers require baseline labs before prescribing GLP-1 medication. Common tests include A1C, lipid panel, kidney function, liver enzymes, and thyroid function. These baselines help your provider monitor changes during treatment and catch any contraindications before you start.
How soon will I see changes in my blood work on GLP-1?
Most people see measurable changes in A1C and fasting glucose within three months. Lipid panel improvements may take three to six months. Liver enzyme improvements often appear within the first six months, especially in people with fatty liver disease.
Can GLP-1 medications affect my thyroid blood work?
GLP-1 medications carry a black box warning about thyroid C-cell tumors based on animal studies. However, clinically significant thyroid changes in humans have not been established. Your provider will monitor TSH at regular intervals as a precaution. If you have a history of medullary thyroid cancer, GLP-1 medications are contraindicated.
Should I fast before getting blood work on GLP-1?
Yes, most providers recommend a 10 to 12 hour fast before lab work, especially for accurate fasting glucose and lipid panel results. Water is fine and encouraged during the fast. Schedule your blood draw in the morning to make fasting easier.
Your Personalized Plan Is Waiting
No two patients are the same, and your protocol shouldn't be either. FormBlends providers create customized treatment plans based on your health profile, goals, and preferences.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
- Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2 (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
- Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3 (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
- Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4 (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
- Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
- Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files. NCHS Data Brief. No. 492. CDC/NCHS. 2023.
- Sumithran P, Prendergast LA, Delbridge E, et al. Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med. 2011;365(17):1597-1604. Doi:10.1056/NEJMoa1105816
This content is provided for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed healthcare provider with any questions about a medical condition or treatment plan.
Last updated: 2026-03-24